• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核苷(酸)类似物临床获批前就已存在的乙肝病毒耐药性替代突变:基于GenBank数据挖掘的生物信息学分析

HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining.

作者信息

Xu Xizhan, Xiang Kuanhui, Su Mingze, Li Yao, Ji Wei, Li Yutang, Zhuang Hui, Li Tong

机构信息

Department of Microbiology and Center of Infectious Disease, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

出版信息

Viruses. 2017 Jul 27;9(8):199. doi: 10.3390/v9080199.

DOI:10.3390/v9080199
PMID:28749433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5580456/
Abstract

Naturally occurring nucleos(t)ide analogue resistance (NUCr) substitution frequencies in the reverse transcriptase (RT) of the hepatitis B virus (HBV) were studied extensively after the clinical approval of nucleos(t)ide analogues (NUCs; year of approval 1998). We aimed to study NUCr substitutions in HBV RT sequences obtained before 1998 and better understand the evolution of RT sequences without NUC pressures. Our strategy was to retrieve HBV sequences from GenBank deposited before 1998. The initial search used the keywords "hepatitis B virus" or "HBV" and 1139 sequences were found. Data analyses included information extraction: sequence quality control and amino acid substitution analysis on 8 primary NUCr and 3 secondary substitution codons. Three hundred and ninety-four RT-containing sequences of 8 genotypes from 25 countries in 4 continents were selected. Twenty-seven (6.9%) sequences were found to harbor substitutions at NUCr-related codons. Secondary substitutions (rtL80V and rtV173G/A/L) occurred more frequently than primary NUCr substitutions (rtI169L; rtA181G; T184A/S; rtS202T/R; rtM204L and rtM250K). Typical amino acid substitutions associated with NUCr were of rtL80V, rtV173L and rtT184A/S. We confirm the presence of naturally occurring typical HBV NUCr substitutions with very low frequencies, and secondary substitutions are more likely to occur than primary NUCr substitutions without the selective pressure of NUCs.

摘要

在核苷(酸)类似物(NUCs;批准年份1998年)获得临床批准后,人们对乙型肝炎病毒(HBV)逆转录酶(RT)中自然发生的核苷(酸)类似物耐药(NUCr)替代频率进行了广泛研究。我们旨在研究1998年之前获得的HBV RT序列中的NUCr替代情况,并更好地了解在没有NUC压力的情况下RT序列的进化。我们的策略是从GenBank中检索1998年之前存入的HBV序列。最初的搜索使用关键词“乙型肝炎病毒”或“HBV”,共找到1139条序列。数据分析包括信息提取:对8个主要NUCr和3个次要替代密码子进行序列质量控制和氨基酸替代分析。从四大洲25个国家的8个基因型中选择了394条含RT的序列。发现27条(6.9%)序列在与NUCr相关的密码子处存在替代。次要替代(rtL80V和rtV173G/A/L)比主要NUCr替代(rtI169L;rtA181G;T184A/S;rtS202T/R;rtM204L和rtM250K)更频繁出现。与NUCr相关的典型氨基酸替代为rtL80V、rtV173L和rtT184A/S。我们证实了自然发生的典型HBV NUCr替代以非常低的频率存在,并且在没有NUC选择压力的情况下,次要替代比主要NUCr替代更有可能发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad82/5580456/976c2da10ab6/viruses-09-00199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad82/5580456/ad960aea407b/viruses-09-00199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad82/5580456/976c2da10ab6/viruses-09-00199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad82/5580456/ad960aea407b/viruses-09-00199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad82/5580456/976c2da10ab6/viruses-09-00199-g002.jpg

相似文献

1
HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining.核苷(酸)类似物临床获批前就已存在的乙肝病毒耐药性替代突变:基于GenBank数据挖掘的生物信息学分析
Viruses. 2017 Jul 27;9(8):199. doi: 10.3390/v9080199.
2
Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.在B2亚型HBeAg阳性慢性乙型肝炎患者中,乙肝病毒逆转录酶/表面蛋白重叠序列中氨基酸替换的较高检出率与较低的血清乙肝病毒DNA和乙肝表面抗原水平相关。
Infect Genet Evol. 2016 Jun;40:275-281. doi: 10.1016/j.meegid.2016.03.019. Epub 2016 Mar 19.
3
Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.在未经治疗的慢性乙型肝炎土耳其患者中,核苷(酸)类似物的天然氨基酸取代。
J Viral Hepat. 2010 Jan;17(1):23-7. doi: 10.1111/j.1365-2893.2009.01149.x. Epub 2009 Jun 28.
4
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.拉米夫定治疗期间出现对核苷(酸)类似物敏感性降低的乙型肝炎病毒准种
J Antimicrob Chemother. 2007 Aug;60(2):341-9. doi: 10.1093/jac/dkm187. Epub 2007 Jun 13.
5
New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.乙型肝炎病毒基因型 H 中耐药部位和 HBsAg 的新氨基酸变化。
J Med Virol. 2015 Jun;87(6):985-92. doi: 10.1002/jmv.24098. Epub 2015 Mar 2.
6
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.HBV D 基因型慢性感染、未接受抗病毒药物治疗的患者中耐药突变的特征。
Antiviral Res. 2011 Nov;92(2):382-5. doi: 10.1016/j.antiviral.2011.08.013. Epub 2011 Sep 5.
7
Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.治疗初治慢性乙型肝炎患者的乙型肝炎病毒逆转录酶突变。
J Med Virol. 2013 Jul;85(7):1155-62. doi: 10.1002/jmv.23608.
8
Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.在中国一家医院中,核苷(酸)类似物初治与经治慢性乙型肝炎患者的 HBV 逆转录酶区潜在抗病毒耐药突变谱的差异。
J Med Virol. 2012 Feb;84(2):207-16. doi: 10.1002/jmv.23182.
9
Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.乙肝病毒rtH55R聚合酶替代对病毒复制及rtM204I/V对核苷/核苷酸类抗病毒药物耐药性的影响
Antivir Ther. 2018;23(1):33-42. doi: 10.3851/IMP3170.
10
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome.超深度焦磷酸测序检测到乙型肝炎病毒基因组中保守的基因组位点,并定量了耐药性氨基酸变化的连锁关系。
PLoS One. 2012;7(5):e37874. doi: 10.1371/journal.pone.0037874. Epub 2012 May 30.

引用本文的文献

1
Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China.来自中国三个地区的705例接受基于拉米夫定的抗逆转录病毒治疗的HIV感染患者的HBV感染特征。
Infect Drug Resist. 2018 Oct 2;11:1635-1644. doi: 10.2147/IDR.S173757. eCollection 2018.
2
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates.靶向乙型肝炎病毒的腺病毒载体疫苗的免疫原性:非人类灵长类动物的非临床安全性评估。
Virol J. 2018 Jul 24;15(1):111. doi: 10.1186/s12985-018-1026-3.

本文引用的文献

1
Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.乙肝病毒rtH55R聚合酶替代对病毒复制及rtM204I/V对核苷/核苷酸类抗病毒药物耐药性的影响
Antivir Ther. 2018;23(1):33-42. doi: 10.3851/IMP3170.
2
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
3
Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.
TDF-ETV 联合治疗中选择高度复制和部分多药耐药 rtS78T HBV 聚合酶突变。
J Hepatol. 2017 Aug;67(2):246-254. doi: 10.1016/j.jhep.2017.03.027. Epub 2017 Apr 7.
4
Viral reverse transcriptases.病毒逆转录酶
Virus Res. 2017 Apr 15;234:153-176. doi: 10.1016/j.virusres.2016.12.019. Epub 2016 Dec 30.
5
Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.在B2亚型HBeAg阳性慢性乙型肝炎患者中,乙肝病毒逆转录酶/表面蛋白重叠序列中氨基酸替换的较高检出率与较低的血清乙肝病毒DNA和乙肝表面抗原水平相关。
Infect Genet Evol. 2016 Jun;40:275-281. doi: 10.1016/j.meegid.2016.03.019. Epub 2016 Mar 19.
6
AASLD guidelines for treatment of chronic hepatitis B.美国肝病研究学会慢性乙型肝炎治疗指南。
Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.
7
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.《亚太地区乙型肝炎管理临床实践指南:2015年更新版》
Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.
8
Anti-HBV Drugs: Progress, Unmet Needs, and New Hope.抗乙肝病毒药物:进展、未满足的需求与新希望。
Viruses. 2015 Sep 15;7(9):4960-77. doi: 10.3390/v7092854.
9
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.乙型肝炎病毒聚合酶rt269位点的替换是一种与多药耐药相关的补偿性突变。
PLoS One. 2015 Aug 31;10(8):e0136728. doi: 10.1371/journal.pone.0136728. eCollection 2015.
10
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.全球慢性乙型肝炎病毒感染患病率的估计:1965 年至 2013 年发表数据的系统评价。
Lancet. 2015 Oct 17;386(10003):1546-55. doi: 10.1016/S0140-6736(15)61412-X. Epub 2015 Jul 28.